Entering text into the input field will update the search result below

Invitae Q1 net loss widens 66% amid rise in R&D, marketing expenses (updated)

May 03, 2022 4:41 PM ETInvitae Corporation (NVTA)By: Jonathan Block, SA News Editor7 Comments

Quarterly results

CharlieAJA/iStock via Getty Images

  • Invitae (NYSE:NVTA) saw its Q1 2022 net loss widen 66% to $181.9M as the genetic test maker was hampered in the quarter by increases in R&D, and sales and marketing costs.
  • Both the net loss

This was corrected on 05/03/2022 at 6:07 PM. This article has been updated to reflect the disclosure of a federal subpoena Invitae has received.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.